Unidoc Health Corp. (UDOC.CN)
CAD 0.3
(-4.76%)
CAD 0.3
(-4.76%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.18 Million CAD | -69.83% |
| 2022 | -1.25 Million CAD | 57.97% |
| 2021 | -2.98 Million CAD | -1158.94% |
| 2020 | -237.32 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.88 Million CAD | -141.22% |
| 2023 Q1 | -691.48 Thousand CAD | -73.13% |
| 2023 FY | - CAD | -69.83% |
| 2023 Q4 | -726.3 Thousand CAD | -129.74% |
| 2023 Q2 | -442.15 Thousand CAD | 36.06% |
| 2023 Q3 | -316.14 Thousand CAD | 28.5% |
| 2022 Q1 | -399.4 Thousand CAD | 61.18% |
| 2022 Q4 | -399.4 Thousand CAD | -107.96% |
| 2022 Q3 | -192.05 Thousand CAD | 28.18% |
| 2022 FY | - CAD | 57.97% |
| 2022 Q2 | -267.39 Thousand CAD | 33.05% |
| 2021 Q3 | -995.68 Thousand CAD | -143.2% |
| 2021 Q1 | -425.83 Thousand CAD | 0.0% |
| 2021 Q4 | -1.02 Million CAD | -3.32% |
| 2021 FY | - CAD | -1158.94% |
| 2021 Q2 | -409.41 Thousand CAD | 3.86% |
| 2020 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AI/ML Innovations Inc. | -1.66 Million CAD | -31.114% |
| Diagnamed Holdings Corp. | -100.27 Thousand CAD | -2077.008% |
| Pangenomic Health Inc. | -2.71 Million CAD | 19.503% |
| nDatalyze Corp. | -290.5 Thousand CAD | -651.429% |
| Treatment.Com International Inc. | -3.64 Million CAD | 40.136% |